NCT00233337View on ClinicalTrials.gov

Efficacy, Safety and Tolerability of Co-artemether in Non-immune Travelers

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2001

Primary Completion Date

August 31, 2005

Study Completion Date

August 31, 2005

Conditions
Acute Uncomplicated P. Falciparum Malaria
Interventions
DRUG

Co-artemether

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY